{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T14:32:35Z","timestamp":1775658755023,"version":"3.50.1"},"reference-count":211,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10142-025-01526-z","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T23:42:46Z","timestamp":1737070966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Role of long non-coding RNAs and natural products in prostate cancer: insights into key signaling pathways"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0136-7096","authenticated-orcid":false,"given":"Ahmed S.","family":"Doghish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif S. Abdel","family":"Mageed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Bakr","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai A.","family":"Abd-Elmawla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghadir A.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman","family":"Hatawsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora M.","family":"Aborehab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rewan","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7728-0923","authenticated-orcid":false,"given":"Mustafa Ahmed","family":"Abdel-Reheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan","family":"Elimam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"1526_CR1","doi-asserted-by":"crossref","unstructured":"Abd-Elmawla MA, ElMonier AA, Gad ES, Khidr HY, Azzam MA (2024a) Implication of Let7b\/AhR\/ARNT\/HMGB1\/RAGE cascade in neuroplasticity disturbances induced by glucocorticoids and the promising reversible effect of 3, 3 diindolymethane: Bidirectional crosstalk of Aryl hydrocarbon receptors. Biochemical Pharmacology: 116692","DOI":"10.1016\/j.bcp.2024.116692"},{"key":"1526_CR2","doi-asserted-by":"crossref","first-page":"113577","DOI":"10.1016\/j.intimp.2024.113577","volume":"143","author":"MA Abd-Elmawla","year":"2024","unstructured":"Abd-Elmawla MA, Elsamanoudie NM, Ismail MF, Hammam OA, Hekmat M (2024b) The interplay of TapSAKI and NEAT-1 as potential modulators in gentamicin-induced acute kidney injury via orchestrating miR-22-3p\/TLR4\/MyD88\/NF-\u049bB\/IL-1 \u03b2 milieu: novel therapeutic approach of Betanin. Int Immunopharmacol 143:113577","journal-title":"Int Immunopharmacol"},{"key":"1526_CR3","doi-asserted-by":"crossref","unstructured":"Ahani M, Ghaderian SMH, Azma MM, Kamali K, Gargari BN, Vojdani S (2022) Association of STAT3, PTPRT, TNK2-AS1, LINC-ROR genes expression level with prostate Cancer and Benign Prostatic Hyperplasia. Int J Cancer Manage 15","DOI":"10.5812\/ijcm.120188"},{"key":"1526_CR4","first-page":"128","volume":"58","author":"J Ahel","year":"2019","unstructured":"Ahel J, Hudorovi\u0107 N, Vi\u010di\u0107-Hudorovi\u0107 V, Nikles H (2019) Tgf-beta in the natural history of prostate cancer. Acta Clin Croatica 58:128\u2013138","journal-title":"Acta Clin Croatica"},{"key":"1526_CR5","doi-asserted-by":"crossref","first-page":"e0177198","DOI":"10.1371\/journal.pone.0177198","volume":"12","author":"RF Al Aameri","year":"2017","unstructured":"Al Aameri RF, Sheth S, Alanisi EM, Borse V, Mukherjea D, Rybak LP, Ramkumar V (2017a) Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: reversal by resveratrol. PLoS ONE 12:e0177198","journal-title":"PLoS ONE"},{"key":"1526_CR6","doi-asserted-by":"crossref","first-page":"e0177198","DOI":"10.1371\/journal.pone.0177198","volume":"12","author":"RFH Al Aameri","year":"2017","unstructured":"Al Aameri RFH, Sheth S, Alanisi EMA, Borse V, Mukherjea D, Rybak LP, Ramkumar V (2017b) Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: reversal by resveratrol. PLoS ONE 12:e0177198","journal-title":"PLoS ONE"},{"key":"1526_CR7","doi-asserted-by":"crossref","first-page":"12094","DOI":"10.3390\/ijms150712094","volume":"15","author":"NG Amado","year":"2014","unstructured":"Amado NG, Predes D, Moreno MM, Carvalho IO, Mendes FA, Abreu JG (2014) Flavonoids and Wnt\/\u03b2-catenin signaling: potential role in colorectal cancer therapies. Int J Mol Sci 15:12094\u201312106","journal-title":"Int J Mol Sci"},{"key":"1526_CR8","first-page":"170","volume":"10","author":"C An","year":"2022","unstructured":"An C, Wang I, Li X, Xia R, Deng F (2022) Long non-coding RNA in prostate cancer. Am J Clin Exp Urol 10:170\u2013179","journal-title":"Am J Clin Exp Urol"},{"key":"1526_CR9","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1158\/1541-7786.MCR-20-0021","volume":"18","author":"AK Angeles","year":"2020","unstructured":"Angeles AK, Heckmann D, Flosdorf N, Duensing S, S\u00fcltmann H (2020) The ERG-regulated LINC00920 promotes prostate cancer cell survival via the 14-3-3\u03f5\u2013FOXO pathway. Mol Cancer Res 18:1545\u20131559","journal-title":"Mol Cancer Res"},{"key":"1526_CR10","doi-asserted-by":"crossref","first-page":"100067","DOI":"10.1016\/j.adcanc.2022.100067","volume":"6","author":"P Anil","year":"2022","unstructured":"Anil P, Ghosh Dastidar S, Banerjee S (2022) Unravelling the role of long non-coding RNAs in prostate carcinoma. Adv Cancer Biology - Metastasis 6:100067","journal-title":"Adv Cancer Biology - Metastasis"},{"key":"1526_CR11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.molmed.2018.01.001","volume":"24","author":"G Arun","year":"2018","unstructured":"Arun G, Diermeier SD, Spector DL (2018) Therapeutic targeting of long non-coding RNAs in Cancer. Trends Mol Med 24:257\u2013277","journal-title":"Trends Mol Med"},{"key":"1526_CR12","doi-asserted-by":"crossref","first-page":"101532","DOI":"10.1016\/j.nantod.2022.101532","volume":"45","author":"M Ashrafizadeh","year":"2022","unstructured":"Ashrafizadeh M, Aghamiri S, Tan SC, Zarrabi A, Sharifi E, Rabiee N, Kadumudi FB, Pirouz AD, Delfi M, Byrappa K (2022a) Nanotechnological approaches in prostate cancer therapy: integration of engineering and biology. Nano Today 45:101532","journal-title":"Nano Today"},{"key":"1526_CR13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13046-022-02293-6","volume":"41","author":"M Ashrafizadeh","year":"2022","unstructured":"Ashrafizadeh M, Paskeh MDA, Mirzaei S, Gholami MH, Zarrabi A, Hashemi F, Hushmandi K, Hashemi M, Nabavi N, Crea F, Ren J, Klionsky DJ, Kumar AP, Wang Y (2022b) Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response. J Exp Clin Cancer Res 41:105","journal-title":"J Exp Clin Cancer Res"},{"key":"1526_CR14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10555-024-10168-9","volume":"43","author":"M Ashrafizadeh","year":"2024","unstructured":"Ashrafizadeh M, Zhang W, Tian Y, Sethi G, Zhang X, Qiu A (2024) Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation. Cancer Metastasis Rev 43:229\u2013260","journal-title":"Cancer Metastasis Rev"},{"key":"1526_CR15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.eururo.2013.05.029","volume":"64","author":"CE Barbieri","year":"2013","unstructured":"Barbieri CE, Bangma CH, Bjartell A, Catto JW, Culig Z, Gr\u00f6nberg H, Luo J, Visakorpi T, Rubin MA (2013) The mutational landscape of prostate cancer. Eur Urol 64:567\u2013576","journal-title":"Eur Urol"},{"key":"1526_CR16","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","volume":"77","author":"A Bhan","year":"2017","unstructured":"Bhan A, Soleimani M, Mandal SS (2017) Long noncoding RNA and Cancer: a New Paradigm. Cancer Res 77:3965\u20133981","journal-title":"Cancer Res"},{"key":"1526_CR17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/jpp\/rgab056","volume":"73","author":"S Bo","year":"2021","unstructured":"Bo S, Lai J, Lin H, Luo X, Zeng Y, Du T (2021) Purpurin, a anthraquinone induces ROS-mediated A549 lung cancer cell apoptosis via inhibition of PI3K\/AKT and proliferation. J Pharm Pharmacol 73:1101\u20131108","journal-title":"J Pharm Pharmacol"},{"key":"1526_CR18","doi-asserted-by":"crossref","first-page":"1269233","DOI":"10.3389\/fphar.2023.1269233","volume":"14","author":"T Bu","year":"2023","unstructured":"Bu T, Li L, Tian J (2023) Unlocking the role of non-coding RNAs in prostate cancer progression: exploring the interplay with the wnt signaling pathway. Front Pharmacol 14:1269233","journal-title":"Front Pharmacol"},{"key":"1526_CR19","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3390\/cells9051261","volume":"9","author":"Q Cai","year":"2020","unstructured":"Cai Q, Dozmorov M, Oh Y (2020) IGFBP-3\/IGFBP-3 receptor system as an anti-tumor and anti-metastatic signaling in cancer. Cells 9:1261","journal-title":"Cells"},{"key":"1526_CR20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cell.2011.09.028","volume":"147","author":"M Cesana","year":"2011","unstructured":"Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I (2011) A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147:358\u2013369","journal-title":"Cell"},{"key":"1526_CR21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.clgc.2021.07.014","volume":"19","author":"J Cham","year":"2021","unstructured":"Cham J, Venkateswaran AR, Bhangoo M (2021) Targeting the PI3K-AKT-mTOR pathway in Castration resistant prostate Cancer: a review article. Clin Genitourin Cancer 19:563. e561-563.e567","journal-title":"Clin Genitourin Cancer"},{"key":"1526_CR24","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3892\/etm.2016.3050","volume":"11","author":"SJ Chen","year":"2016","unstructured":"Chen SJ, Yao XD, Peng BO, Xu YF, Wang GC, Huang J, Liu M, Zheng JH (2016) Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9. Experimental Therapeutic Med 11:1243\u20131248","journal-title":"Experimental Therapeutic Med"},{"key":"1526_CR23","doi-asserted-by":"crossref","first-page":"552907","DOI":"10.3389\/fonc.2020.552907","volume":"10","author":"J Chen","year":"2020","unstructured":"Chen J, Wang F, Xu H, Xu L, Chen D, Wang J, Huang S, Wen Y, Fang L (2020) Long non-coding RNA SNHG1 regulates the Wnt\/\u03b2-catenin and PI3K\/AKT\/mTOR signaling pathways via EZH2 to affect the proliferation, apoptosis, and autophagy of prostate cancer cell. Front Oncol 10:552907","journal-title":"Front Oncol"},{"key":"1526_CR22","doi-asserted-by":"crossref","unstructured":"Chen J-L, Yang S-Y, Zhang J-H, Qiu M-L, Li Y-L, Wang J-H, Shao M, Lu J-X, Zhang Y-B, Wang G-C (2024) Novel filicinic acid-based meroterpenoids with antiproliferative activity against prostate cancer PC-3 cells from Dryopteris wallichiana","DOI":"10.22541\/au.172666991.17272585\/v1"},{"key":"1526_CR25","doi-asserted-by":"crossref","first-page":"32779","DOI":"10.1038\/srep32779","volume":"6","author":"J Chinison","year":"2016","unstructured":"Chinison J, Aguilar JS, Avalos A, Huang Y, Wang Z, Cameron DJ, Hao J (2016) Triptonide effectively inhibits Wnt\/\u03b2-catenin signaling via C-terminal transactivation domain of \u03b2-catenin. Sci Rep 6:32779","journal-title":"Sci Rep"},{"key":"1526_CR26","first-page":"45","volume":"6","author":"E Cordover","year":"2020","unstructured":"Cordover E, Minden A, Lehman S, Zhao O (2020) Signaling pathways downstream to receptor tyrosine kinases: targets for cancer treatment. J Cancer Metastasis Treat 6:45","journal-title":"J Cancer Metastasis Treat"},{"key":"1526_CR27","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/genes12071094","volume":"12","author":"C Cuesta","year":"2021","unstructured":"Cuesta C, Ar\u00e9valo-Alameda C, Castellano E (2021) The importance of being PI3K in the RAS signaling network. Genes 12:1094","journal-title":"Genes"},{"key":"1526_CR28","doi-asserted-by":"crossref","first-page":"12113","DOI":"10.18632\/aging.202919","volume":"13","author":"Z Cui","year":"2021","unstructured":"Cui Z, Gao H, Yan N, Dai Y, Wang H, Wang M, Wang J, Zhang D, Sun P, Qi T (2021) LncRNA PlncRNA-1 accelerates the progression of prostate cancer by regulating PTEN\/Akt axis. Aging 13:12113","journal-title":"Aging"},{"key":"1526_CR29","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1158\/1940-6207.CAPR-10-0370","volume":"4","author":"G Deep","year":"2011","unstructured":"Deep G, Gangar SC, Agarwal C, Agarwal R (2011) Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells. Cancer Prev Res 4:1222\u20131232","journal-title":"Cancer Prev Res"},{"key":"1526_CR30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/cells9010198","volume":"9","author":"U Degirmenci","year":"2020","unstructured":"Degirmenci U, Wang M, Hu J (2020) Targeting aberrant RAS\/RAF\/MEK\/ERK signaling for cancer therapy. Cells 9:198","journal-title":"Cells"},{"key":"1526_CR31","first-page":"2224","volume":"13","author":"H Deng","year":"2021","unstructured":"Deng H, Zhu B, Dong Z, Jiang H, Zhao X, Wu S (2021) Mir-214-5p targeted by LncRNA DANCR mediates TGF-\u03b2 signaling pathway to accelerate proliferation, migration and inhibit apoptosis of prostate cancer cells. Am J Translational Res 13:2224","journal-title":"Am J Translational Res"},{"key":"1526_CR32","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1101\/gr.132159.111","volume":"22","author":"T Derrien","year":"2012","unstructured":"Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG, Lagarde J, Veeravalli L, Ruan X, Ruan Y, Lassmann T, Carninci P, Brown JB, Lipovich L, Gonzalez JM, Thomas M, Davis CA, Shiekhattar R, Gingeras TR, Hubbard TJ, Notredame C, Harrow J, Guig\u00f3 R (2012) The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 22:1775\u20131789","journal-title":"Genome Res"},{"key":"1526_CR33","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/mnfr.201100141","volume":"55","author":"S Dhar","year":"2011","unstructured":"Dhar S, Hicks C, Levenson AS (2011) Resveratrol and prostate cancer: promising role for microRNAs. Mol Nutr Food Res 55:1219\u20131229","journal-title":"Mol Nutr Food Res"},{"key":"1526_CR34","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2217\/fon.10.117","volume":"6","author":"I Diaz-Laviada","year":"2010","unstructured":"Diaz-Laviada I (2010) Effect of capsaicin on prostate cancer cells. Future Oncol 6:1545\u20131550","journal-title":"Future Oncol"},{"key":"1526_CR35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11011-024-01456-y","volume":"40","author":"AS Doghish","year":"2024","unstructured":"Doghish AS, Abd-Elmawla MA, Hatawsh A, Zaki MB, Aborehab NM, Radwan AF, Moussa R, Eisa MA, Mageed SSA, Mohammed OA (2024a) Unraveling the role of LncRNAs in glioblastoma progression: insights into signaling pathways and therapeutic potential. Metab Brain Dis 40:42","journal-title":"Metab Brain Dis"},{"key":"1526_CR36","doi-asserted-by":"crossref","first-page":"130426","DOI":"10.1016\/j.ijbiomac.2024.130426","volume":"264","author":"AS Doghish","year":"2024","unstructured":"Doghish AS, Radwan AF, Zaki MB, Elfar N, Moussa R, Walash Z, Alhamshry NAA, Mohammed OA, Abdel-Reheim MA, Elimam H (2024b) Decoding the role of long non-coding RNAs in gallbladder cancer pathogenesis: a review focus on signaling pathways interplay. Int J Biol Macromol 264:130426","journal-title":"Int J Biol Macromol"},{"key":"1526_CR37","doi-asserted-by":"crossref","first-page":"100681","DOI":"10.1016\/j.drup.2020.100681","volume":"49","author":"J Dong","year":"2020","unstructured":"Dong J, Qin Z, Zhang W-D, Cheng G, Yehuda AG, Ashby CR Jr, Chen Z-S, Cheng X-D, Qin J-J (2020) Medicinal chemistry strategies to discover P-glycoprotein inhibitors: an update. Drug Resist Updates 49:100681","journal-title":"Drug Resist Updates"},{"key":"1526_CR39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.pcan.4500399","volume":"3","author":"T Dorai","year":"2000","unstructured":"Dorai T, Gehani N, Katz A (2000) Therapeutic potential of curcumin in human prostate cancer\u2014I. Curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells. Prostate Cancer Prostatic Dis 3:84\u201393","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1526_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pros.10359","volume":"60","author":"T Dorai","year":"2004","unstructured":"Dorai T, Dutcher JP, Dempster DW, Wiernik PH (2004) Therapeutic potential of curcumin in prostate cancer\u2014IV: interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells. Prostate 60:1\u201317","journal-title":"Prostate"},{"key":"1526_CR40","doi-asserted-by":"crossref","first-page":"20089","DOI":"10.18632\/oncotarget.24015","volume":"9","author":"J Dou","year":"2018","unstructured":"Dou J, Wang Z, Ma L, Peng B, Mao K, Li C, Su M, Zhou C, Peng G (2018) Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence. Oncotarget 9:20089","journal-title":"Oncotarget"},{"key":"1526_CR41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nprot.2016.006","volume":"11","author":"J Drost","year":"2016","unstructured":"Drost J, Karthaus WR, Gao D, Driehuis E, Sawyers CL, Chen Y, Clevers H (2016) Organoid culture systems for prostate epithelial and cancer tissue. Nat Protoc 11:347\u2013358","journal-title":"Nat Protoc"},{"key":"1526_CR42","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.3390\/cancers13194854","volume":"13","author":"C Ebersbach","year":"2021","unstructured":"Ebersbach C, Beier A-MK, Thomas C, Erb HH (2021) Impact of STAT proteins in tumor progress and therapy resistance in advanced and metastasized prostate cancer. Cancers 13:4854","journal-title":"Cancers"},{"key":"1526_CR43","doi-asserted-by":"crossref","first-page":"110541","DOI":"10.1016\/j.intimp.2023.110541","volume":"121","author":"NA El-Boghdady","year":"2023","unstructured":"El-Boghdady NA, Abd El-Hakk S, Abd-Elmawla MA (2023) The lncRNAs UCA1 and CRNDE target miR-145\/TLR4\/NF-\u049bB\/TNF-\u03b1 axis in acetic acid-induced ulcerative colitis model: the beneficial role of 3, 3-Diindolylmethane. Int Immunopharmacol 121:110541","journal-title":"Int Immunopharmacol"},{"key":"1526_CR44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12032-024-02455-w","volume":"41","author":"H Elimam","year":"2024","unstructured":"Elimam H, Abdel Mageed SS, Hatawsh A, Moussa R, Radwan AF, Elfar N, Alhamshry NAA, Abd-Elmawla MA, Mohammed OA, Zaki MB, Doghish AS (2024a) Unraveling the influence of LncRNA in gastric cancer pathogenesis: a comprehensive review focus on signaling pathways interplay. Med Oncol 41:218","journal-title":"Med Oncol"},{"key":"1526_CR45","first-page":"1","volume":"1","author":"H Elimam","year":"2024","unstructured":"Elimam H, Alhamshry NA, Hatawsh A, Elfar N, Moussa R, Radwan AF, Abd-Elmawla MA, Elkashlan AM, Zaki MB, Abdel-Reheim MA (2024b) Natural products and long noncoding RNA signatures in gallbladder cancer: a review focuses on pathogenesis, diagnosis, and drug resistance. Naunyn Schmiedebergs Arch Pharmacol 1:1\u201323","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1526_CR46","doi-asserted-by":"crossref","unstructured":"Elimam H, Eldeib MG, Kizilaslan EZ, Alhamshry NAA, Ashour AE, Elfar N, Abdel-Wahab MM, Zaki MB, Mohammed OA, Radwan AF, Abdel-Reheim MA, Moussa R, Doghish AS (2024c) Exploring the interplay of natural products and long non-coding RNAs in colorectal cancer: pathogenesis, diagnosis, and overcoming drug resistance. Naunyn Schmiedebergs Arch Pharmacol","DOI":"10.1007\/s00210-024-03425-9"},{"key":"1526_CR47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10142-024-01450-8","volume":"24","author":"H Elimam","year":"2024","unstructured":"Elimam H, Moussa R, Radwan AF, Hatawsh A, Elfar N, Alhamshry NAA, Abd-Elmawla MA, Aborehab NM, Zaki MB, Mageed SSA, Mohammed OA, Abdel-Reheim MA, Doghish AS (2024d) LncRNAs orchestration of gastric cancer - particular emphasis on the etiology, diagnosis, and treatment resistance. Funct Integr Genomics 24:175","journal-title":"Funct Integr Genomics"},{"key":"1526_CR48","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41588-018-0298-2","volume":"51","author":"S Fanucchi","year":"2019","unstructured":"Fanucchi S, Fok ET, Dalla E, Shibayama Y, B\u00f6rner K, Chang EY, Stoychev S, Imakaev M, Grimm D, Wang KC, Li G, Sung WK, Mhlanga MM (2019) Immune genes are primed for robust transcription by proximal long noncoding RNAs located in nuclear compartments. Nat Genet 51:138\u2013150","journal-title":"Nat Genet"},{"key":"1526_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-020-00074-4","volume":"21","author":"B Fathi Dizaji","year":"2020","unstructured":"Fathi Dizaji B (2020a) Strategies to target long non-coding RNAs in cancer treatment: progress and challenges. Egypt J Med Hum Genet 21:1\u201315","journal-title":"Egypt J Med Hum Genet"},{"key":"1526_CR50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s43042-020-00074-4","volume":"21","author":"B Fathi Dizaji","year":"2020","unstructured":"Fathi Dizaji B (2020b) Strategies to target long non-coding RNAs in cancer treatment: progress and challenges. Egypt J Med Hum Genet 21:41","journal-title":"Egypt J Med Hum Genet"},{"key":"1526_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-12-507","volume":"12","author":"LB Ferreira","year":"2012","unstructured":"Ferreira LB, Palumbo A, de Mello KD, Sternberg C, Caetano MS, de Oliveira FL, Neves AF, Nasciutti LE, Goulart LR, Gimba ERP (2012) PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling. BMC Cancer 12:1\u201315","journal-title":"BMC Cancer"},{"key":"1526_CR52","doi-asserted-by":"crossref","unstructured":"Figel S, H Gelman I (2011) Focal adhesion kinase controls prostate cancer progression via intrinsic kinase and scaffolding functions. Anti-cancer agents in Medicinal Chemistry (formerly current Medicinal Chemistry-Anti-cancer agents). 11:607\u2013616","DOI":"10.2174\/187152011796817646"},{"key":"1526_CR53","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1158\/1535-7163.MCT-15-0951","volume":"15","author":"ML Flores","year":"2016","unstructured":"Flores ML, Castilla C, Gasca J, Medina R, Perez-Valderrama B, Romero F, Jap\u00f3n MA, S\u00e1ez C (2016) Loss of PKC\u03b4 induces prostate cancer resistance to paclitaxel through activation of Wnt\/\u03b2-Catenin pathway and Mcl-1 accumulation. Mol Cancer Ther 15:1713\u20131725","journal-title":"Mol Cancer Ther"},{"key":"1526_CR54","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3390\/cancers12051122","volume":"12","author":"M Friedrich","year":"2020","unstructured":"Friedrich M, Wiedemann K, Reiche K, Puppel S-H, Pfeifer G, Zipfel I, Binder S, Koehl U, M\u00fcller GA, Engeland K (2020) The role of lncRNAs TAPIR-1 and-2 as diagnostic markers and potential therapeutic targets in prostate cancer. Cancers 12:1122","journal-title":"Cancers"},{"key":"1526_CR55","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/13685538.2019.1670157","volume":"23","author":"X Fu","year":"2020","unstructured":"Fu X, Wang D, Shu T, Cui D, Fu Q (2020) LncRNA NR2F2-AS1 positively regulates CDK4 to promote cancer cell proliferation in prostate carcinoma. Aging Male 23:1073\u20131079","journal-title":"Aging Male"},{"key":"1526_CR56","doi-asserted-by":"crossref","unstructured":"Gholami MH, Abbaspour A, Tajik F, Zabolian A, Ma Z (2023) Long non-coding RNAs (lncRNAs) in cancer therapy response: Biological aspects. NON-CODING RNA TRANSCRIPTS IN CANCER THERAPY: pre-clinical and clinical implications. World Scientific, pp 157\u2013187","DOI":"10.1142\/9789811267390_0007"},{"key":"1526_CR57","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","volume":"154","author":"LA Gilbert","year":"2013","unstructured":"Gilbert LA, Larson MH, Morsut L, Liu Z, Brar GA, Torres SE, Stern-Ginossar N, Brandman O, Whitehead EH, Doudna JA, Lim WA, Weissman JS, Qi LS (2013) CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154:442\u2013451","journal-title":"Cell"},{"key":"1526_CR58","doi-asserted-by":"crossref","first-page":"e2000027","DOI":"10.1002\/bies.202000027","volume":"42","author":"J Graf","year":"2020","unstructured":"Graf J, Kretz M (2020) From structure to function: Route to understanding lncRNA mechanism. BioEssays 42:e2000027","journal-title":"BioEssays"},{"key":"1526_CR59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","volume":"21","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Karin M (2010) Dangerous liaisons: STAT3 and NF-\u03baB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 21:11\u201319","journal-title":"Cytokine Growth Factor Rev"},{"key":"1526_CR60","first-page":"1","volume":"18","author":"P Gu","year":"2019","unstructured":"Gu P, Chen X, Xie R, Xie W, Huang L, Dong W, Han J, Liu X, Shen J, Huang J (2019) A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer. Mol Cancer 18:1\u201314","journal-title":"Mol Cancer"},{"key":"1526_CR61","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jep.2011.01.015","volume":"134","author":"DN Gunadharini","year":"2011","unstructured":"Gunadharini DN, Elumalai P, Arunkumar R, Senthilkumar K, Arunakaran J (2011) Induction of apoptosis and inhibition of PI3K\/Akt pathway in PC-3 and LNCaP prostate cancer cells by ethanolic neem leaf extract. J Ethnopharmacol 134:644\u2013650","journal-title":"J Ethnopharmacol"},{"key":"1526_CR62","doi-asserted-by":"crossref","first-page":"154957","DOI":"10.1016\/j.prp.2023.154957","volume":"253","author":"MA Hakami","year":"2024","unstructured":"Hakami MA, Hazazi A, Abdulaziz O, Almasoudi HH, Alhazmi AYM, Alkhalil SS, Alharthi NS, Alhuthali HM, Almalki WH, Gupta G, Khan FR (2024) HOTAIR: a key regulator of the Wnt\/\u03b2-catenin signaling cascade in cancer progression and treatment. Pathol - Res Pract 253:154957","journal-title":"Pathol - Res Pract"},{"key":"1526_CR64","unstructured":"Han P-B, Ji X-J, Zhang M, Gao L-Y (2018) Upregulation of lncRNA LINC00473 promotes radioresistance of HNSCC cells through activating Wnt\/\u03b2-catenin signaling pathway. European Review for Medical & Pharmacological. Sciences 22"},{"key":"1526_CR63","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1389202916666150707155851","volume":"16","author":"C Han Li","year":"2015","unstructured":"Han Li C, Chen Y (2015) Small and long non-coding RNAs: novel targets in Perspective Cancer Therapy. Curr Genomics 16:319\u2013326","journal-title":"Curr Genomics"},{"key":"1526_CR65","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12032-024-02538-8","volume":"41","author":"A Hatawsh","year":"2024","unstructured":"Hatawsh A, Al-Haddad RH, Okafor UG, Diab LM, Dekanoidze N, Abdulwahab AA, Mohammed OA, Doghish AS, Moussa R, Elimam H (2024) Mitoepigenetics pathways and natural compounds: a dual approach to combatting hepatocellular carcinoma. Med Oncol 41:302","journal-title":"Med Oncol"},{"key":"1526_CR66","first-page":"97","volume":"20","author":"P He","year":"2020","unstructured":"He P, Xiong G, Guo W, Jiang G, Li Y, Li H (2020) Long non-coding RNA CCAT2 promotes prostate cancer cell proliferation and invasion by regulating the Wnt\/\u03b2-catenin signaling pathway. Oncol Lett 20:97","journal-title":"Oncol Lett"},{"key":"1526_CR67","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.18632\/oncotarget.13475","volume":"8","author":"K Hientz","year":"2017","unstructured":"Hientz K, Mohr A, Bhakta-Guha D, Efferth T (2017) The role of p53 in cancer drug resistance and targeted chemotherapy. Oncotarget 8:8921","journal-title":"Oncotarget"},{"key":"1526_CR68","doi-asserted-by":"crossref","unstructured":"Hu X-Y, Hou P-F, Li T-T, Quan H-Y, Li M-L, Lin T, Liu J-J, Bai J, Zheng J-N (2018) The roles of Wnt\/\u03b2-catenin signaling pathway related lncRNAs in cancer. International journal of biological sciences 14: 2003","DOI":"10.7150\/ijbs.27977"},{"key":"1526_CR69","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1139\/bcb-2020-0377","volume":"99","author":"H-IM Ibrahim","year":"2021","unstructured":"Ibrahim H-IM, Ismail MB, Ammar RB, Ahmed EA (2021) Thidiazuron suppresses breast cancer via targeting miR-132 and dysregulation of the PI3K\u2013Akt signaling pathway mediated by the miR-202-5p\u2013PTEN axis. Biochem Cell Biol 99:374\u2013384","journal-title":"Biochem Cell Biol"},{"key":"1526_CR70","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1002\/ptr.6647","volume":"34","author":"M Imran","year":"2020","unstructured":"Imran M, Aslam Gondal T, Atif M, Shahbaz M, Batool Qaisarani T, Hanif Mughal M, Salehi B, Martorell M, Sharifi-Rad J (2020) Apigenin as an anticancer agent. Phytother Res 34:1812\u20131828","journal-title":"Phytother Res"},{"key":"1526_CR71","doi-asserted-by":"crossref","unstructured":"Jang JY, Im E, Kim ND (2022) Mechanism of Resveratrol-Induced programmed cell death and New Drug Discovery against Cancer: a review. Int J Mol Sci 23","DOI":"10.3390\/ijms232213689"},{"key":"1526_CR72","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.5489\/cuaj.784","volume":"4","author":"B Jankovic","year":"2010","unstructured":"Jankovic B, Loblaw DA, Nam R (2010) Capsaicin may slow PSA doubling time: case report and literature review. Can Urol Association J 4:E9","journal-title":"Can Urol Association J"},{"key":"1526_CR73","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s11033-019-04618-9","volume":"46","author":"Y Jia","year":"2019","unstructured":"Jia Y, Chen L, Guo S, Li Y (2019) Baicalin induced colon cancer cells apoptosis through miR-217\/DKK1-mediated inhibition of wnt signaling pathway. Mol Biol Rep 46:1693\u20131700","journal-title":"Mol Biol Rep"},{"key":"1526_CR74","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3892\/mco.2020.2146","volume":"13","author":"G Jiang","year":"2020","unstructured":"Jiang G, Su Z, Liang X, Huang Y, Lan Z, Jiang X (2020) Long non-coding RNAs in prostate tumorigenesis and therapy (review). Mol Clin Oncol 13:76","journal-title":"Mol Clin Oncol"},{"key":"1526_CR75","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jep.2009.10.035","volume":"129","author":"M Kandouz","year":"2010","unstructured":"Kandouz M, Alachkar A, Zhang L, Dekhil H, Chehna F, Yasmeen A, Al Moustafa A-E (2010) Teucrium Polium plant extract inhibits cell invasion and motility of human prostate cancer cells via the restoration of the E-cadherin\/catenin complex. J Ethnopharmacol 129:410\u2013415","journal-title":"J Ethnopharmacol"},{"key":"1526_CR76","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40495-023-00333-z","volume":"9","author":"C Kishore","year":"2023","unstructured":"Kishore C, Zi X (2023) Wnt signaling and therapeutic resistance in castration-resistant prostate Cancer. Curr Pharmacol Rep 9:261\u2013274","journal-title":"Curr Pharmacol Rep"},{"key":"1526_CR77","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41417-024-00822-3","volume":"31","author":"A Kohvakka","year":"2024","unstructured":"Kohvakka A, Sattari M, N\u00e4ttinen J, Aapola U, Gregorov\u00e1 P, Tammela TL, Uusitalo H, Sarin LP, Visakorpi T, Latonen L (2024) Long noncoding RNA EPCART regulates translation through PI3K\/AKT\/mTOR pathway and PDCD4 in prostate cancer. Cancer Gene Ther 31:1536\u20131546","journal-title":"Cancer Gene Ther"},{"key":"1526_CR78","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/MCB.22.14.5222-5234.2002","volume":"22","author":"N Kotaja","year":"2002","unstructured":"Kotaja N, Karvonen U, J\u00e4nne OA, Palvimo JJ (2002) PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol Cell Biol 22:5222\u20135234","journal-title":"Mol Cell Biol"},{"key":"1526_CR79","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/1878-0261.12634","volume":"14","author":"C Lang","year":"2020","unstructured":"Lang C, Dai Y, Wu Z, Yang Q, He S, Zhang X, Guo W, Lai Y, Du H, Wang H (2020) SMAD3\/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF\u2010\u03b2 signaling promotes prostate cancer bone metastasis. Mol Oncol 14:808\u2013828","journal-title":"Mol Oncol"},{"key":"1526_CR80","doi-asserted-by":"publisher","unstructured":"Le TK, Duong QH, Baylot V, Fargette C, Baboudjian M, Colleaux L, Ta\u00efeb D, Rocchi P (2023) Castration-resistant prostate Cancer: from uncovered resistance mechanisms to current treatments. Cancers 15. https:\/\/doi.org\/10.3390\/cancers15205047","DOI":"10.3390\/cancers15205047"},{"key":"1526_CR82","first-page":"1","volume":"3","author":"T-J Lee","year":"2004","unstructured":"Lee T-J, Sartor O, Luftig RB, Koochekpour S (2004) Saposin C promotes survival and prevents apoptosis via PI3K\/Akt-dependent pathway in prostate cancer cells. Mol Cancer 3:1\u201314","journal-title":"Mol Cancer"},{"key":"1526_CR81","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jmoldx.2014.06.009","volume":"16","author":"B Lee","year":"2014","unstructured":"Lee B, Mazar J, Aftab MN, Qi F, Shelley J, Li JL, Govindarajan S, Valerio F, Rivera I, Thurn T, Tran TA, Kameh D, Patel V, Perera RJ (2014) Long noncoding RNAs as putative biomarkers for prostate cancer detection. J Mol Diagn 16:615\u2013626","journal-title":"J Mol Diagn"},{"key":"1526_CR83","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.bbrc.2018.10.045","volume":"505","author":"Y-J Lee","year":"2018","unstructured":"Lee Y-J, Oh J-E, Lee S-H (2018) Arctigenin shows preferential cytotoxicity to acidity-tolerant prostate carcinoma PC-3 cells through ROS-mediated mitochondrial damage and the inhibition of PI3K\/Akt\/mTOR pathway. Biochem Biophys Res Commun 505:1244\u20131250","journal-title":"Biochem Biophys Res Commun"},{"key":"1526_CR84","doi-asserted-by":"crossref","unstructured":"Lei ZN, Tian Q, Teng QX, Wurpel JND, Zeng L, Pan Y, Chen ZS (2023) Understanding and targeting resistance mechanisms in cancer. MedComm (2020) 4: e265","DOI":"10.1002\/mco2.265"},{"key":"1526_CR87","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1158\/0008-5472.CAN-06-3066","volume":"67","author":"M Li","year":"2007","unstructured":"Li M, Zhang Z, Hill DL, Wang H, Zhang R (2007) Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K\/mTOR\/ETS2 pathway. Cancer Res 67:1988\u20131996","journal-title":"Cancer Res"},{"key":"1526_CR89","doi-asserted-by":"crossref","first-page":"27707","DOI":"10.1074\/jbc.M802759200","volume":"283","author":"Y Li","year":"2008","unstructured":"Li Y, Wang Z, Kong D, Li R, Sarkar SH, Sarkar FH (2008) Regulation of Akt\/FOXO3a\/GSK-3\u03b2\/AR signaling network by isoflavone in prostate cancer cells. J Biol Chem 283:27707\u201327716","journal-title":"J Biol Chem"},{"key":"1526_CR86","unstructured":"Li J-B, Liu F, Zhang B-P, Bai W-K, Cheng W, Zhang Y-H, Yu L-J (2017) LncRNA625 modulates prostate cancer cells proliferation and apoptosis through regulating the Wnt\/\u03b2-catenin pathway by targeting miR-432. European Review for Medical & Pharmacological Sciences 21"},{"key":"1526_CR85","doi-asserted-by":"crossref","unstructured":"Li B, Guo Z, Liang Q, Zhou H, Luo Y, He S, Lin Z (2019) lncRNA DGCR5 up-regulates TGF-\u03b21, increases cancer cell stemness and predicts survival of prostate cancer patients. Cancer Manage Res: 10657\u201310663","DOI":"10.2147\/CMAR.S231112"},{"key":"1526_CR88","first-page":"1","volume":"20","author":"W Li","year":"2020","unstructured":"Li W, Yang G, Yang D, Li D, Sun Q (2020) LncRNA LEF1-AS1 promotes metastasis of prostatic carcinoma via the Wnt\/\u03b2-catenin pathway. Cancer Cell Int 20:1\u201312","journal-title":"Cancer Cell Int"},{"key":"1526_CR90","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/jcp.25494","volume":"232","author":"W Lim","year":"2017","unstructured":"Lim W, Jeong M, Bazer FW, Song G (2017a) Coumestrol inhibits proliferation and migration of prostate cancer cells by regulating AKT, ERK1\/2, and JNK MAPK cell signaling cascades. J Cell Physiol 232:862\u2013871","journal-title":"J Cell Physiol"},{"key":"1526_CR91","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/jcb.25729","volume":"118","author":"W Lim","year":"2017","unstructured":"Lim W, Park S, Bazer FW, Song G (2017b) Naringenin-induced apoptotic cell death in prostate cancer cells is mediated via the PI3K\/AKT and MAPK signaling pathways. J Cell Biochem 118:1118\u20131131","journal-title":"J Cell Biochem"},{"key":"1526_CR92","first-page":"786","volume":"23","author":"W Lim","year":"2017","unstructured":"Lim W, Yang C, Jeong M, Bazer FW, Song G (2017c) Coumestrol induces mitochondrial dysfunction by stimulating ROS production and calcium ion influx into mitochondria in human placental choriocarcinoma cells. MHR: Basic Sci Reproductive Med 23:786\u2013802","journal-title":"MHR: Basic Sci Reproductive Med"},{"key":"1526_CR93","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.gene.2017.08.008","volume":"631","author":"T Liu","year":"2017","unstructured":"Liu T, Chi H, Chen J, Chen C, Huang Y, Xi H, Xue J, Si Y (2017) Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR. Gene 631:29\u201338","journal-title":"Gene"},{"key":"1526_CR94","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.omto.2021.11.005","volume":"23","author":"Y Liu","year":"2021","unstructured":"Liu Y, Ding W, Yu W, Zhang Y, Ao X, Wang J (2021) Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer. Mol Ther Oncolytics 23:458\u2013476","journal-title":"Mol Ther Oncolytics"},{"key":"1526_CR95","doi-asserted-by":"crossref","first-page":"e978","DOI":"10.1002\/ctm2.978","volume":"12","author":"UG Lo","year":"2022","unstructured":"Lo UG, Chen YA, Cen J, Deng S, Luo J, Zhau H, Ho L, Lai CH, Mu P, Chung LW (2022) The driver role of JAK-STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy\u2010and castration\u2010resistant prostate cancer. Clin Translational Med 12:e978","journal-title":"Clin Translational Med"},{"key":"1526_CR96","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.3390\/ijms23073826","volume":"23","author":"D Loizzo","year":"2022","unstructured":"Loizzo D, Pandolfo SD, Rogers D, Cerrato C, di Meo NA, Autorino R, Mirone V, Ferro M, Porta C, Stella A (2022) Novel insights into autophagy and prostate cancer: a comprehensive review. Int J Mol Sci 23:3826","journal-title":"Int J Mol Sci"},{"key":"1526_CR98","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.cellsig.2012.07.009","volume":"24","author":"W Lu","year":"2012","unstructured":"Lu W, Lin C, King TD, Chen H, Reynolds RC, Li Y (2012) Silibinin inhibits Wnt\/\u03b2-catenin signaling by suppressing wnt co-receptor LRP6 expression in human prostate and breast cancer cells. Cell Signal 24:2291\u20132296","journal-title":"Cell Signal"},{"key":"1526_CR99","doi-asserted-by":"crossref","unstructured":"Lu X, Chen D, Yang F, Xing N (2020) Quercetin inhibits epithelial-to-mesenchymal transition (EMT) process and promotes apoptosis in prostate cancer via downregulating lncRNA MALAT1. Cancer Manage Res: 1741\u20131750","DOI":"10.2147\/CMAR.S241093"},{"key":"1526_CR97","doi-asserted-by":"crossref","first-page":"e15232","DOI":"10.7717\/peerj.15232","volume":"11","author":"L Lu","year":"2023","unstructured":"Lu L, Tian Z, Lu J, Jiang M, Chen J, Guo S, Huang Y (2023) LINC00106\/RPS19BP1\/p53 axis promotes the proliferation and migration of human prostate cancer cells. PeerJ 11:e15232","journal-title":"PeerJ"},{"key":"1526_CR100","first-page":"383","volume":"16","author":"Y Lv","year":"2018","unstructured":"Lv Y, Song G, Li P (2018) Correlation of SOCS\u20131 gene with onset and prognosis of breast cancer. Oncol Lett 16:383\u2013387","journal-title":"Oncol Lett"},{"key":"1526_CR101","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen L-L, Chen R, Dean C, Dinger ME, Fitzgerald KA, Gingeras TR, Guttman M, Hirose T, Huarte M, Johnson R, Kanduri C, Kapranov P, Lawrence JB, Lee JT, Mendell JT, Mercer TR, Moore KJ, Nakagawa S, Rinn JL, Spector DL, Ulitsky I, Wan Y, Wilusz JE, Wu M (2023) Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol 24:430\u2013447","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1526_CR102","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.molcel.2012.11.021","volume":"49","author":"CA Melo","year":"2013","unstructured":"Melo CA, Drost J, Wijchers PJ, van de Werken H, de Wit E, Oude Vrielink JA, Elkon R, Melo SA, L\u00e9veill\u00e9 N, Kalluri R, de Laat W, Agami R (2013) eRNAs are required for p53-dependent enhancer activity and gene transcription. Mol Cell 49:524\u2013535","journal-title":"Mol Cell"},{"key":"1526_CR103","first-page":"1","volume":"20","author":"L Meng","year":"2020","unstructured":"Meng L, Li Z, Chen Y, Liu D, Liu Z (2020) LINC00689 promotes prostate cancer progression via regulating miR-496\/CTNNB1 to activate wnt pathway. Cancer Cell Int 20:1\u201312","journal-title":"Cancer Cell Int"},{"key":"1526_CR104","doi-asserted-by":"crossref","first-page":"105705","DOI":"10.1016\/j.jff.2023.105705","volume":"108","author":"SM Meybodi","year":"2023","unstructured":"Meybodi SM, Rezaei P, Faraji N, Jamehbozorg K, Ashna S, Shokri F, Goleij P, Moradi S, Kashian M, Arefnezhad R, Sahebkar A (2023) Curcumin and its novel formulations for the treatment of hepatocellular carcinoma: new trends and future perspectives in cancer therapy. J Funct Foods 108:105705","journal-title":"J Funct Foods"},{"key":"1526_CR105","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ajhg.2018.03.018","volume":"102","author":"TL Mighell","year":"2018","unstructured":"Mighell TL, Evans-Dutson S, O\u2019Roak BJ (2018) A saturation mutagenesis approach to understanding PTEN lipid phosphatase activity and genotype-phenotype relationships. Am J Hum Genet 102:943\u2013955","journal-title":"Am J Hum Genet"},{"key":"1526_CR106","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13046-022-02406-1","volume":"41","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Paskeh MDA, Okina E, Gholami MH, Hushmandi K, Hashemi M, Kalu A, Zarrabi A, Nabavi N, Rabiee N (2022a) Molecular Landscape of LncRNAs in prostate Cancer: a focus on pathways and therapeutic targets for intervention. J Experimental Clin Cancer Res 41:214","journal-title":"J Experimental Clin Cancer Res"},{"key":"1526_CR107","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13046-022-02406-1","volume":"41","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Paskeh MDA, Okina E, Gholami MH, Hushmandi K, Hashemi M, Kalu A, Zarrabi A, Nabavi N, Rabiee N, Sharifi E, Karimi-Maleh H, Ashrafizadeh M, Kumar AP, Wang Y (2022b) Molecular Landscape of LncRNAs in prostate Cancer: a focus on pathways and therapeutic targets for intervention. J Exp Clin Cancer Res 41:214","journal-title":"J Exp Clin Cancer Res"},{"key":"1526_CR108","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13046-022-02406-1","volume":"41","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Paskeh MDA, Okina E, Gholami MH, Hushmandi K, Hashemi M, Kalu A, Zarrabi A, Nabavi N, Rabiee N, Sharifi E, Karimi-Maleh H, Ashrafizadeh M, Kumar AP, Wang Y (2022c) Molecular Landscape of LncRNAs in prostate Cancer: a focus on pathways and therapeutic targets for intervention. J Experimental Clin Cancer Res 41:214","journal-title":"J Experimental Clin Cancer Res"},{"key":"1526_CR109","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1038\/ncomms8743","volume":"6","author":"T Mondal","year":"2015","unstructured":"Mondal T, Subhash S, Vaid R, Enroth S, Uday S, Reinius B, Mitra S, Mohammed A, James AR, Hoberg E, Moustakas A, Gyllensten U, Jones SJ, Gustafsson CM, Sims AH, Westerlund F, Gorab E, Kanduri C (2015) MEG3 long noncoding RNA regulates the TGF-\u03b2 pathway genes through formation of RNA-DNA triplex structures. Nat Commun 6:7743","journal-title":"Nat Commun"},{"key":"1526_CR110","first-page":"1028","volume":"21","author":"A Morales-Becerril","year":"2022","unstructured":"Morales-Becerril A, Aranda-Lara L, Isaac-Olive K, Ocampo-Garcia BE, Morales-Avila E (2022) Nanocarriers for delivery of siRNA as gene silencing mediator. EXCLI J 21:1028\u20131052","journal-title":"EXCLI J"},{"key":"1526_CR111","doi-asserted-by":"crossref","first-page":"120752","DOI":"10.1016\/j.lfs.2022.120752","volume":"305","author":"M Motallebi","year":"2022","unstructured":"Motallebi M, Bhia M, Rajani HF, Bhia I, Tabarraei H, Mohammadkhani N, Pereira-Silva M, Kasaii MS, Nouri-Majd S, Mueller A-L (2022) Naringenin: a potential flavonoid phytochemical for cancer therapy. Life Sci 305:120752","journal-title":"Life Sci"},{"key":"1526_CR112","doi-asserted-by":"crossref","first-page":"8852","DOI":"10.1038\/sj.onc.1206048","volume":"21","author":"A Mukhopadhyay","year":"2002","unstructured":"Mukhopadhyay A, Banerjee S, Stafford LJ, Xia C, Liu M, Aggarwal BB (2002) Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 21:8852\u20138861","journal-title":"Oncogene"},{"key":"1526_CR113","doi-asserted-by":"crossref","unstructured":"Natarelli L, Weber C (2022) A Non-Canonical Link between Non-Coding RNAs and Cardiovascular Diseases. Biomedicines 10","DOI":"10.3390\/biomedicines10020445"},{"key":"1526_CR114","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gde.2008.01.020","volume":"18","author":"WE Naugler","year":"2008","unstructured":"Naugler WE, Karin M (2008) NF-\u03baB and cancer\u2014identifying targets and mechanisms. Curr Opin Genet Dev 18:19\u201326","journal-title":"Curr Opin Genet Dev"},{"key":"1526_CR115","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM (2020) Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod 83:770\u2013803","journal-title":"J Nat Prod"},{"key":"1526_CR116","doi-asserted-by":"crossref","first-page":"1144836","DOI":"10.3389\/fphar.2023.1144836","volume":"14","author":"JA Ngum","year":"2023","unstructured":"Ngum JA, Tatang FJ, Toumeni MH, Nguengo SN, Simo USF, Mezajou CF, Kameni C, Ngongang NN, Tchinda MF, Dongho Dongmo FF, Akami M, Ngane Ngono AR, Tamgue O (2023) An overview of natural products that modulate the expression of non-coding RNAs involved in oxidative stress and inflammation-associated disorders. Front Pharmacol 14:1144836","journal-title":"Front Pharmacol"},{"key":"1526_CR117","doi-asserted-by":"crossref","unstructured":"Nicholas TR, Strittmatter BG, Hollenhorst PC (2019) Oncogenic ETS factors in prostate cancer. Prostate Cancer: Cell Genetic Mech Disease Dev Progression: 409\u2013436","DOI":"10.1007\/978-3-030-32656-2_18"},{"key":"1526_CR118","doi-asserted-by":"crossref","first-page":"e20180329","DOI":"10.1590\/1678-4685-gmb-2018-0329","volume":"43","author":"M N\u00f3brega","year":"2020","unstructured":"N\u00f3brega M, Cili\u00e3o HL, Souza MFd S, MRd, Serpeloni JM, Fuganti PE, C\u00f3lus IMS (2020) Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer. Genet Mol Biology 43:e20180329","journal-title":"Genet Mol Biology"},{"key":"1526_CR119","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41580-021-00447-6","volume":"23","author":"T Nojima","year":"2022","unstructured":"Nojima T, Proudfoot NJ (2022) Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics. Nat Rev Mol Cell Biol 23:389\u2013406","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1526_CR120","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/iju.15424","volume":"31","author":"D Obinata","year":"2024","unstructured":"Obinata D, Takayama K, Inoue S, Takahashi S (2024) Exploring androgen receptor signaling pathway in prostate cancer: a path to new discoveries. Int J Urol 31:590\u2013597","journal-title":"Int J Urol"},{"key":"1526_CR121","doi-asserted-by":"crossref","first-page":"881641","DOI":"10.3389\/fonc.2022.881641","volume":"12","author":"OA Ojo","year":"2022","unstructured":"Ojo OA, Adeyemo TR, Rotimi D, Batiha GE-S, Mostafa-Hedeab G, Iyobhebhe ME, Elebiyo TC, Atunwa B, Ojo AB, Lima CMG (2022) Anticancer properties of curcumin against colorectal cancer: a review. Front Oncol 12:881641","journal-title":"Front Oncol"},{"key":"1526_CR122","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/bs.enz.2015.06.002","volume":"37","author":"M Ono","year":"2015","unstructured":"Ono M, Takeshima M, Nakano S (2015) Mechanism of the anticancer effect of lycopene (tetraterpenoids). Enzymes 37:139\u2013166","journal-title":"Enzymes"},{"key":"1526_CR123","doi-asserted-by":"crossref","unstructured":"Orafidiya F, Deng L, Bevan CL, Fletcher CE (2022) Crosstalk between Long non Coding RNAs, microRNAs and DNA damage repair in prostate Cancer. New Therapeutic Opportunities? Cancers (Basel, p 14","DOI":"10.3390\/cancers14030755"},{"key":"1526_CR124","doi-asserted-by":"crossref","first-page":"264","DOI":"10.22271\/phyto.2022.v11.i5d.14509","volume":"11","author":"S Patra","year":"2022","unstructured":"Patra S, Pal S, Ghosh K, Pradhan S, Chakrabarti S (2022) A review on phytoestrogens: current status and future direction. J Pharmacognosy Phytochemistry 11:264\u2013277","journal-title":"J Pharmacognosy Phytochemistry"},{"key":"1526_CR125","doi-asserted-by":"crossref","first-page":"10627","DOI":"10.1111\/jcmm.17000","volume":"25","author":"N Peng","year":"2021","unstructured":"Peng N, Zhang Z, Wang Y, Yang M, Fan J, Wang Q, Deng L, Chen D, Cai Y, Li Q (2021) Down-regulated LINC00115 inhibits prostate cancer cell proliferation and invasion via targeting miR\u2010212\u20105p\/FZD5\/Wnt\/\u03b2\u2010catenin axis. J Cell Mol Med 25:10627\u201310637","journal-title":"J Cell Mol Med"},{"key":"1526_CR126","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2217\/epi-2019-0316","volume":"12","author":"P Pucci","year":"2020","unstructured":"Pucci P, Venalainen E, Alborelli I, Quagliata L, Hawkes C, Mather R, Romero I, Rigas SH, Wang Y, Crea F (2020) LncRNA HORAS5 promotes taxane resistance in castration-resistant prostate cancer via a BCL2A1-dependent mechanism. Epigenomics 12:1123\u20131138","journal-title":"Epigenomics"},{"key":"1526_CR127","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","volume":"152","author":"LS Qi","year":"2013","unstructured":"Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, Lim WA (2013) Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152:1173\u20131183","journal-title":"Cell"},{"key":"1526_CR128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrg.2015.10","volume":"17","author":"JJ Quinn","year":"2016","unstructured":"Quinn JJ, Chang HY (2016a) Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet 17:47\u201362","journal-title":"Nat Rev Genet"},{"key":"1526_CR129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrg.2015.10","volume":"17","author":"JJ Quinn","year":"2016","unstructured":"Quinn JJ, Chang HY (2016b) Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet 17:47\u201362","journal-title":"Nat Rev Genet"},{"key":"1526_CR130","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1242\/jcs.00963","volume":"117","author":"JS Rawlings","year":"2004","unstructured":"Rawlings JS, Rosler KM, Harrison DA (2004) The JAK\/STAT signaling pathway. J Cell Sci 117:1281\u20131283","journal-title":"J Cell Sci"},{"key":"1526_CR131","doi-asserted-by":"crossref","unstructured":"Rodriguez-Berriguete G, Fraile B, Martinez-Onsurbe P, Olmedilla G, Paniagua R, Royuela M (2012) MAP Kinases and Prostate Cancer. J Signal Transduct 2012: 169170","DOI":"10.1155\/2012\/169170"},{"key":"1526_CR132","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/antiox13040418","volume":"13","author":"V Romanucci","year":"2024","unstructured":"Romanucci V, Pagano R, Kandhari K, Zarrelli A, Petrone M, Agarwal C, Agarwal R, Di Fabio G (2024) 7-O-tyrosyl Silybin Derivatives as a Novel Set of Anti-prostate Cancer compounds. Antioxidants 13:418","journal-title":"Antioxidants"},{"key":"1526_CR133","doi-asserted-by":"publisher","unstructured":"Saghafi T, Taheri RA, Parkkila S, Zolfaghari Emameh R (2019) Phytochemicals as modulators of long non-coding RNAs and inhibitors of Cancer-Related Carbonic anhydrases. Int J Mol Sci 20. https:\/\/doi.org\/10.3390\/ijms20122939","DOI":"10.3390\/ijms20122939"},{"key":"1526_CR134","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1158\/0008-5472.CAN-19-3460","volume":"80","author":"S Saha","year":"2020","unstructured":"Saha S, Kiran M, Kuscu C, Chatrath A, Wotton D, Mayo MW, Dutta A (2020) Long noncoding RNA DRAIC inhibits prostate cancer progression by interacting with IKK to inhibit NF-\u03baB activation. Cancer Res 80:950\u2013963","journal-title":"Cancer Res"},{"key":"1526_CR135","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41585-022-00677-z","volume":"20","author":"V Sailer","year":"2023","unstructured":"Sailer V, von Amsberg G, Duensing S, Kirfel J, Lieb V, Metzger E, Offermann A, Pantel K, Schuele R, Taubert H (2023) Experimental in vitro, ex vivo and in vivo models in prostate cancer research. Nat Reviews Urol 20:158\u2013178","journal-title":"Nat Reviews Urol"},{"key":"1526_CR136","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/carcin\/bgp044","volume":"30","author":"M Saleem","year":"2009","unstructured":"Saleem M, Murtaza I, Tarapore RS, Suh Y, Adhami VM, Johnson JJ, Siddiqui IA, Khan N, Asim M, Hafeez BB, Shekhani MT, Li B, Mukhtar H (2009) Lupeol inhibits proliferation of human prostate cancer cells by targeting beta-catenin signaling. Carcinogenesis 30:808\u2013817","journal-title":"Carcinogenesis"},{"key":"1526_CR137","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.bbrc.2008.05.138","volume":"372","author":"AM S\u00e1nchez","year":"2008","unstructured":"S\u00e1nchez AM, Mart\u00ednez-Botas J, Malagarie-Cazenave S, Olea N, Vara D, Lasunci\u00f3n MA, D\u00edaz-Laviada I (2008) Induction of the endoplasmic reticulum stress protein GADD153\/CHOP by capsaicin in prostate PC-3 cells: a microarray study. Biochem Biophys Res Commun 372:785\u2013791","journal-title":"Biochem Biophys Res Commun"},{"key":"1526_CR138","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/pharmaceutics14020329","volume":"14","author":"BG S\u00e1nchez","year":"2022","unstructured":"S\u00e1nchez BG, Bort A, Mora-Rodr\u00edguez JM, D\u00edaz-Laviada I (2022) The natural chemotherapeutic capsaicin activates AMPK through LKB1 kinase and TRPV1 receptors in prostate cancer cells. Pharmaceutics 14:329","journal-title":"Pharmaceutics"},{"key":"1526_CR139","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molcel.2016.11.029","volume":"65","author":"M Schlackow","year":"2017","unstructured":"Schlackow M, Nojima T, Gomes T, Dhir A, Carmo-Fonseca M, Proudfoot NJ (2017) Distinctive patterns of transcription and RNA Processing for Human lincRNAs. Mol Cell 65:25\u201338","journal-title":"Mol Cell"},{"key":"1526_CR140","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt AM, Chang HY (2016) Long noncoding RNAs in Cancer pathways. Cancer Cell 29:452\u2013463","journal-title":"Cancer Cell"},{"key":"1526_CR141","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1101\/gad.590910","volume":"24","author":"KM Schmitz","year":"2010","unstructured":"Schmitz KM, Mayer C, Postepska A, Grummt I (2010) Interaction of noncoding RNA with the rDNA promoter mediates recruitment of DNMT3b and silencing of rRNA genes. Genes Dev 24:2264\u20132269","journal-title":"Genes Dev"},{"key":"1526_CR142","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mce.2017.02.008","volume":"462","author":"JA Schneider","year":"2018","unstructured":"Schneider JA, Logan SK (2018) Revisiting the role of Wnt\/beta-catenin signaling in prostate cancer. Mol Cell Endocrinol 462:3\u20138","journal-title":"Mol Cell Endocrinol"},{"key":"1526_CR143","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/mc.22324","volume":"55","author":"S Selvaraj","year":"2016","unstructured":"Selvaraj S, Sun Y, Sukumaran P, Singh BB (2016) Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway. Mol Carcinog 55:818\u2013831","journal-title":"Mol Carcinog"},{"key":"1526_CR144","doi-asserted-by":"crossref","first-page":"1382787","DOI":"10.3389\/fphar.2024.1382787","volume":"15","author":"Y Seo","year":"2024","unstructured":"Seo Y, Lee S, Kim M, Kim D, Jeong SB, Das R, Sultana A, Park S, Nhiem NX, Huong PTT (2024) Discovery of a novel natural compound, vitekwangin B, with ANO1 protein reduction properties and anticancer potential. Front Pharmacol 15:1382787","journal-title":"Front Pharmacol"},{"key":"1526_CR145","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1093\/nar\/gkz108","volume":"47","author":"Z Shang","year":"2019","unstructured":"Shang Z, Yu J, Sun L, Tian J, Zhu S, Zhang B, Dong Q, Jiang N, Flores-Morales A, Chang C (2019) LncRNA PCAT1 activates AKT and NF-\u03baB signaling in castration-resistant prostate cancer by regulating the PHLPP\/FKBP51\/IKK\u03b1 complex. Nucleic Acids Res 47:4211\u20134225","journal-title":"Nucleic Acids Res"},{"key":"1526_CR146","first-page":"905","volume":"30","author":"S Shankar","year":"2007","unstructured":"Shankar S, Srivastava RK (2007) Involvement of Bcl-2 family members, phosphatidylinositol 3\u2019-kinase\/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Int J Oncol 30:905\u2013918","journal-title":"Int J Oncol"},{"key":"1526_CR147","doi-asserted-by":"crossref","first-page":"939070","DOI":"10.3389\/fmolb.2022.939070","volume":"9","author":"D Shen","year":"2022","unstructured":"Shen D, Peng H, Xia C, Deng Z, Tong X, Wang G, Qian K (2022) The role of long non-coding RNAs in epithelial-mesenchymal transition-related signaling pathways in prostate cancer. Front Mol Biosci 9:939070","journal-title":"Front Mol Biosci"},{"key":"1526_CR148","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cpt.2022.12.003","volume":"1","author":"B Shree","year":"2023","unstructured":"Shree B, Das K, Sharma V (2023) Emerging role of transforming growth factor-\u03b2-regulated long non-coding RNAs in prostate cancer pathogenesis. Cancer Pathogenesis Therapy 1:195\u2013204","journal-title":"Cancer Pathogenesis Therapy"},{"key":"1526_CR149","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1208\/s12248-011-9300-y","volume":"13","author":"L Shu","year":"2011","unstructured":"Shu L, Khor TO, Lee J-H, Boyanapalli SS, Huang Y, Wu T-Y, Saw CL-L, Cheung K-L, Kong A-NT (2011) Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells. AAPS J 13:606\u2013614","journal-title":"AAPS J"},{"key":"1526_CR151","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s11095-010-0089-7","volume":"27","author":"S Shukla","year":"2010","unstructured":"Shukla S, Gupta S (2010) Apigenin: a promising molecule for cancer prevention. Pharm Res 27:962\u2013978","journal-title":"Pharm Res"},{"key":"1526_CR150","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/carcin\/bgt316","volume":"35","author":"S Shukla","year":"2013","unstructured":"Shukla S, Bhaskaran N, Babcook MA, Fu P, MacLennan GT, Gupta S (2013) Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K\/Akt\/FoxO pathway. Carcinogenesis 35:452\u2013460","journal-title":"Carcinogenesis"},{"key":"1526_CR152","doi-asserted-by":"crossref","first-page":"31216","DOI":"10.18632\/oncotarget.5157","volume":"6","author":"S Shukla","year":"2015","unstructured":"Shukla S, Kanwal R, Shankar E, Datt M, Chance MR, Fu P, MacLennan GT, Gupta S (2015) Apigenin blocks IKK\u03b1 activation and suppresses prostate cancer progression. Oncotarget 6:31216\u201331232","journal-title":"Oncotarget"},{"key":"1526_CR153","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3390\/cancers11091390","volume":"11","author":"SK Singh","year":"2019","unstructured":"Singh SK, Apata T, Gordetsky JB, Singh R (2019) Docetaxel combined with thymoquinone induces apoptosis in prostate cancer cells via inhibition of the PI3K\/AKT signaling pathway. Cancers 11:1390","journal-title":"Cancers"},{"key":"1526_CR154","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1124\/mol.107.040253","volume":"72","author":"G-Y Song","year":"2007","unstructured":"Song G-Y, Lee J-H, Cho M, Park B-S, Kim D-E, Oh S (2007) Decursin suppresses human androgen-independent PC3 prostate cancer cell proliferation by promoting the degradation of \u03b2-catenin. Mol Pharmacol 72:1599\u20131606","journal-title":"Mol Pharmacol"},{"key":"1526_CR155","first-page":"682","volume":"35","author":"X Song","year":"2020","unstructured":"Song X, Wang H, Wu J, Sun Y (2020) Long noncoding RNA SOX2-OT knockdown inhibits proliferation and metastasis of prostate cancer cells through modulating the miR-452-5p\/HMGB3 axis and inactivating Wnt\/\u03b2-catenin pathway. Cancer Biother Radiopharm 35:682\u2013695","journal-title":"Cancer Biother Radiopharm"},{"key":"1526_CR156","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo C-J, Chen L-L, Huarte M (2021) Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 22:96\u2013118","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1526_CR157","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.3390\/cells10102509","volume":"10","author":"R Sugiura","year":"2021","unstructured":"Sugiura R, Satoh R, Takasaki T (2021) ERK: a double-edged sword in cancer. ERK-dependent apoptosis as a potential therapeutic strategy for cancer. Cells 10:2509","journal-title":"Cells"},{"key":"1526_CR158","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.2174\/0929867327666201111142307","volume":"28","author":"M Suhail","year":"2021","unstructured":"Suhail M, Khan MS, Ahmad A, Zughaibi TA, Husain FM, Rehman MT, Tabrez S (2021) Flavonoids and PI3K\/Akt\/mTOR signaling cascade: a potential crosstalk in anticancer treatment. Curr Med Chem 28:8083\u20138097","journal-title":"Curr Med Chem"},{"key":"1526_CR159","doi-asserted-by":"crossref","first-page":"e3344","DOI":"10.1002\/jgm.3344","volume":"23","author":"W Sun","year":"2021","unstructured":"Sun W, Zu S, Shao G, Wang W, Gong F (2021) Long non-coding DANCR targets mir-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK\/PI3K\/AKT\/GSK3\u03b2\/snail pathway. J Gene Med 23:e3344","journal-title":"J Gene Med"},{"key":"1526_CR160","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3892\/ijo.2022.5400","volume":"61","author":"X Sun","year":"2022","unstructured":"Sun X, Xin S, Zhang Y, Jin L, Liu X, Zhang J, Mei W, Zhang B, Ma W, Ye L (2022) Long non\u2013coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway Corrigendum in \/10.3892\/ijo.2023.5593. Int J Oncol 61:110","journal-title":"Int J Oncol"},{"key":"1526_CR161","doi-asserted-by":"crossref","first-page":"e35368","DOI":"10.1371\/journal.pone.0035368","volume":"7","author":"V Sundram","year":"2012","unstructured":"Sundram V, Chauhan SC, Ebeling M, Jaggi M (2012) Curcumin attenuates \u03b2-catenin signaling in prostate cancer cells through activation of protein kinase D1. PLoS ONE 7:e35368","journal-title":"PLoS ONE"},{"key":"1526_CR162","doi-asserted-by":"crossref","first-page":"1123101","DOI":"10.3389\/fonc.2023.1123101","volume":"13","author":"M Taheri","year":"2023","unstructured":"Taheri M, Badrlou E, Hussen BM, Kashi AH, Ghafouri-Fard S, Baniahmad A (2023) Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer. Front Oncol 13:1123101","journal-title":"Front Oncol"},{"key":"1526_CR163","doi-asserted-by":"crossref","unstructured":"Tang Y-Q, Jaganath I, Manikam R, Sekaran SD (2013) Phyllanthus Suppresses Prostate Cancer Cell, PC-3, Proliferation and Induces Apoptosis through Multiple Signalling Pathways (MAPKs, PI3K\/Akt, NF\u03baB, and Hypoxia). Evidence\u2010Based Complementary and Alternative Medicine 2013: 609581","DOI":"10.1155\/2013\/609581"},{"key":"1526_CR164","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3390\/ijms22020632","volume":"22","author":"K Taniue","year":"2021","unstructured":"Taniue K, Akimitsu N (2021) The functions and unique features of LncRNAs in Cancer Development and Tumorigenesis. Int J Mol Sci 22:632","journal-title":"Int J Mol Sci"},{"key":"1526_CR165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12263-009-0152-3","volume":"5","author":"M-H Teiten","year":"2010","unstructured":"Teiten M-H, Gaascht F, Eifes S, Dicato M, Diederich M (2010) Chemopreventive potential of curcumin in prostate cancer. Genes Nutr 5:61\u201374","journal-title":"Genes Nutr"},{"key":"1526_CR166","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3390\/biom10111536","volume":"10","author":"D Termini","year":"2020","unstructured":"Termini D, Den Hartogh DJ, Jaglanian A, Tsiani E (2020) Curcumin against prostate cancer: current evidence. Biomolecules 10:1536","journal-title":"Biomolecules"},{"key":"1526_CR167","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.3390\/cancers15174212","volume":"15","author":"MK Thomsen","year":"2023","unstructured":"Thomsen MK, Busk M (2023) Pre-clinical models to study human prostate Cancer. Cancers 15:4212","journal-title":"Cancers"},{"key":"1526_CR168","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ebiom.2016.04.028","volume":"8","author":"I Van Audenhove","year":"2016","unstructured":"Van Audenhove I, Gettemans J (2016) Nanobodies as versatile tools to Understand, diagnose, visualize and treat Cancer. EBioMedicine 8:40\u201348","journal-title":"EBioMedicine"},{"key":"1526_CR169","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M Van de Wetering","year":"2015","unstructured":"Van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A, van Houdt W, van Gorp J, Taylor-Weiner A, Kester L (2015) Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161:933\u2013945","journal-title":"Cell"},{"key":"1526_CR170","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/pros.23013","volume":"75","author":"NA Venier","year":"2015","unstructured":"Venier NA, Yamamoto T, Sugar LM, Adomat H, Fleshner NE, Klotz LH, Venkateswaran V (2015) Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model. Prostate 75:1300\u20131311","journal-title":"Prostate"},{"key":"1526_CR171","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/1389450116666150907100715","volume":"17","author":"D Verzella","year":"2016","unstructured":"Verzella D, Fischietti M, Capece D, Vecchiotti D, Del Vecchio F, Cicciarelli G, Mastroiaco V, Tessitore A, Alesse E, Zazzeroni F (2016) Targeting the NF-\u03baB pathway in prostate cancer: a promising therapeutic approach? Curr Drug Targets 17:311\u2013320","journal-title":"Curr Drug Targets"},{"key":"1526_CR172","first-page":"5160","volume":"16","author":"B Wan","year":"2018","unstructured":"Wan B, Wu HY, Lv DJ, Zhou XM, Zhong LR, Lei B, Zhang SB, Mao XM (2018) Downregulation of lncRNA PVT1 expression inhibits proliferation and migration by regulating p38 expression in prostate cancer. Oncol Lett 16:5160\u20135166","journal-title":"Oncol Lett"},{"key":"1526_CR178","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1093\/hmg\/ddq354","volume":"19","author":"Y Wang","year":"2010","unstructured":"Wang Y, Romigh T, He X, Orloff MS, Silverman RH, Heston WD, Eng C (2010) Resveratrol regulates the PTEN\/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines. Hum Mol Genet 19:4319\u20134329","journal-title":"Hum Mol Genet"},{"key":"1526_CR176","doi-asserted-by":"crossref","first-page":"BSR20180790","DOI":"10.1042\/BSR20180790","volume":"38","author":"L Wang","year":"2018","unstructured":"Wang L, Zhang X, Sheng L, Qiu C, Luo R (2018a) LINC00473 promotes the taxol resistance via miR-15a in colorectal cancer. Biosci Rep 38:BSR20180790","journal-title":"Biosci Rep"},{"key":"1526_CR177","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/carcin\/bgy063","volume":"39","author":"W Wang","year":"2018","unstructured":"Wang W, Qin J-J, Li X, Tao G, Wang Q, Wu X, Zhou J, Zi X, Zhang R (2018b) Prevention of prostate cancer by natural product MDM2 inhibitor GS25: in vitro and in vivo activities and molecular mechanisms. Carcinogenesis 39:1026\u20131036","journal-title":"Carcinogenesis"},{"key":"1526_CR173","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/pros.23840","volume":"79","author":"D Wang","year":"2019","unstructured":"Wang D, Wan X, Zhang Y, Kong Z, Lu Y, Sun X, Huang Y, Ji C, Li D, Luo J (2019a) A novel androgen-reduced prostate\u2010specific lncRNA, PSLNR, inhibits prostate\u2010cancer progression in part by regulating the p53\u2010dependent pathway. Prostate 79:1379\u20131393","journal-title":"Prostate"},{"key":"1526_CR179","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/cbin.11194","volume":"43","author":"YC Wang","year":"2019","unstructured":"Wang YC, He WY, Dong CH, Pei L, Ma YL (2019b) lncRNA HCG11 regulates cell progression by targeting miR-543 and regulating AKT\/mTOR pathway in prostate cancer. Cell Biol Int 43:1453\u20131462","journal-title":"Cell Biol Int"},{"key":"1526_CR175","first-page":"e13897","volume":"53","author":"L Wang","year":"2021","unstructured":"Wang L, Wang L, Wang Q, Yosefi B, Wei S, Wang X, Shen D (2021) The function of long noncoding RNA HOTAIRM1 in the progression of prostate cancer cells. Andrologia 53:e13897","journal-title":"Andrologia"},{"key":"1526_CR174","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1080\/14728222.2023.2293757","volume":"27","author":"J Wang","year":"2023","unstructured":"Wang J, Ben-David R, Mehrazin R, Yang W, Tewari AK, Kyprianou N (2023) Novel signatures of prostate cancer progression and therapeutic resistance. Expert Opin Ther Targets 27:1195\u20131206","journal-title":"Expert Opin Ther Targets"},{"key":"1526_CR180","doi-asserted-by":"crossref","unstructured":"Weng W, Liu C, Li G, Ruan Q, Li H, Lin N, Chen G (2021) Long non-\u2013coding RNA SNHG16 functions as a tumor activator by sponging miR\u2013373\u20133p to regulate the TGF\u2013\u03b2\u2013R2\/SMAD pathway in prostate cancer. Mol Med Rep 24","DOI":"10.3892\/mmr.2021.12483"},{"key":"1526_CR181","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/01635580903285023","volume":"61","author":"K Wertz","year":"2009","unstructured":"Wertz K (2009) Lycopene effects contributing to prostate health. Nutr Cancer 61:775\u2013783","journal-title":"Nutr Cancer"},{"key":"1526_CR182","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.tig.2017.05.004","volume":"33","author":"H Wu","year":"2017","unstructured":"Wu H, Yang L, Chen LL (2017) The diversity of long noncoding RNAs and their generation. Trends Genet 33:540\u2013552","journal-title":"Trends Genet"},{"key":"1526_CR183","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/cam4.1809","volume":"8","author":"H Wu","year":"2019","unstructured":"Wu H, Zou Q, He H, Liang Y, Lei M, Zhou Q, Fan D, Shen L (2019) Long non-coding RNA PCAT6 targets miR\u2010204 to modulate the chemoresistance of colorectal cancer cells to 5\u2010fluorouracil\u2010based treatment through HMGA2 signaling. Cancer Med 8:2484\u20132495","journal-title":"Cancer Med"},{"key":"1526_CR184","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1080\/21655979.2021.2020393","volume":"13","author":"X Xi","year":"2022","unstructured":"Xi X, Hu Z, Wu Q, Hu K, Cao Z, Zhou J, Liao J, Zhang Z, Hu Y, Zhong X (2022) High expression of small nucleolar RNA host gene 3 predicts poor prognosis and promotes bone metastasis in prostate cancer by activating transforming growth factor-beta signaling. Bioengineered 13:1895\u20131907","journal-title":"Bioengineered"},{"key":"1526_CR186","doi-asserted-by":"crossref","first-page":"BSR20191850","DOI":"10.1042\/BSR20191850","volume":"40","author":"Z Xing","year":"2020","unstructured":"Xing Z, Li S, Liu Z, Zhang C, Meng M, Bai Z (2020) The long non-coding RNA LINC00473 contributes to cell proliferation via JAK-STAT3 signaling pathway by regulating miR-195-5p\/SEPT2 axis in prostate cancer. Biosci Rep 40:BSR20191850","journal-title":"Biosci Rep"},{"key":"1526_CR185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3892\/ijmm.2021.4926","volume":"47","author":"P Xing","year":"2021","unstructured":"Xing P, Wang Y, Zhang L, Ma C, Lu J (2021) Knockdown of lncRNA MIR4435\u20132HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells\u2009<\u2009em\u2009>\u2009in vitro\u2009and <\u2009em\u2009>\u2009in vivo\u2009by blocking the activation of the FAK\/AKT\/\u03b2\u2013catenin signaling pathway. Int J Mol Med 47:93","journal-title":"Int J Mol Med"},{"key":"1526_CR187","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3892\/or.2016.4791","volume":"36","author":"S Xu","year":"2016","unstructured":"Xu S, Yi X-M, Tang C-P, Ge J-P, Zhang Z-Y, Zhou W-Q (2016) Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma. Oncol Rep 36:10\u201322","journal-title":"Oncol Rep"},{"key":"1526_CR188","doi-asserted-by":"crossref","first-page":"BSR20210093","DOI":"10.1042\/BSR20210093","volume":"41","author":"Y Xu","year":"2021","unstructured":"Xu Y, Fang R, Shao J, Cai Z (2021) Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K\/Akt pathway. Biosci Rep 41:BSR20210093","journal-title":"Biosci Rep"},{"key":"1526_CR189","doi-asserted-by":"crossref","unstructured":"Xue D, Zhou C, Lu H, Xu R, Xu X, He X (2016) LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT\/mTOR signaling pathway. Tumour Biol","DOI":"10.1007\/s13277-016-5429-8"},{"key":"1526_CR190","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.18632\/aging.103007","volume":"12","author":"K Yan","year":"2020","unstructured":"Yan K, Hou L, Liu T, Jiao W, Ma Q, Fang Z, Zhang S, Song D, Liu J, Gao X (2020) lncRNA OGFRP1 functions as a ceRNA to promote the progression of prostate cancer by regulating SARM1 level via miR-124-3p. Aging 12:8880","journal-title":"Aging"},{"key":"1526_CR191","doi-asserted-by":"crossref","unstructured":"Yan Y, Liu J, Xu Z, Ye M, Li J (2021) lncRNA PCAT14 Is a Diagnostic Marker for Prostate Cancer and Is Associated with Immune Cell Infiltration. Dis Markers 2021: 9494619","DOI":"10.1155\/2021\/9494619"},{"key":"1526_CR193","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nature12451","volume":"500","author":"L Yang","year":"2013","unstructured":"Yang L, Lin C, Jin C, Yang JC, Tanasa B, Li W, Merkurjev D, Ohgi KA, Meng D, Zhang J (2013) lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature 500:598\u2013602","journal-title":"Nature"},{"key":"1526_CR192","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1080\/09168451.2017.1387048","volume":"81","author":"J Yang","year":"2017","unstructured":"Yang J, Li C, Mudd A, Gu X (2017) LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer. Biosci Biotechnol Biochem 81:2301\u20132306","journal-title":"Biosci Biotechnol Biochem"},{"key":"1526_CR194","doi-asserted-by":"crossref","first-page":"13909","DOI":"10.3390\/ijms241813909","volume":"24","author":"X Yang","year":"2023","unstructured":"Yang X, Du Y, Luo L, Xu X, Xiong S, Yang X, Guo L, Liang T (2023) Deciphering the enigmatic Influence: non-coding RNAs orchestrating Wnt\/\u03b2-Catenin signaling pathway in Tumor Progression. Int J Mol Sci 24:13909","journal-title":"Int J Mol Sci"},{"key":"1526_CR195","first-page":"169","volume":"20","author":"M Ye","year":"2020","unstructured":"Ye M, Tian H, Lin S, Mo J, Li Z, Chen X, Liu J (2020) Resveratrol inhibits proliferation and promotes apoptosis via the androgen receptor splicing variant 7 and PI3K\/AKT signaling pathway in LNCaP prostate cancer cells. Oncol Lett 20:169","journal-title":"Oncol Lett"},{"key":"1526_CR196","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1158\/1535-7163.MCT-19-0095","volume":"18","author":"Z You","year":"2019","unstructured":"You Z, Liu C, Wang C, Ling Z, Wang Y, Wang Y, Zhang M, Chen S, Xu B, Guan H (2019) LncRNA CCAT1 promotes prostate cancer cell proliferation by interacting with DDX5 and MIR-28-5P. Mol Cancer Ther 18:2469\u20132479","journal-title":"Mol Cancer Ther"},{"key":"1526_CR198","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.omtn.2019.11.021","volume":"19","author":"Y Yu","year":"2020","unstructured":"Yu Y, Gao F, He Q, Li G, Ding G (2020) lncRNA UCA1 functions as a ceRNA to promote prostate cancer progression via sponging miR143. Mol Therapy-Nucleic Acids 19:751\u2013758","journal-title":"Mol Therapy-Nucleic Acids"},{"key":"1526_CR197","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12935-022-02637-4","volume":"22","author":"C Yu","year":"2022","unstructured":"Yu C, Fan Y, Zhang Y, Liu L, Guo G (2022) LINC00893 inhibits the progression of prostate cancer through miR-3173-5p\/SOCS3\/JAK2\/STAT3 pathway. Cancer Cell Int 22:228","journal-title":"Cancer Cell Int"},{"key":"1526_CR199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-020-01219-0","volume":"19","author":"L Yuan","year":"2020","unstructured":"Yuan L, Xu Z-Y, Ruan S-M, Mo S, Qin J-J, Cheng X-D (2020) Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance. Mol Cancer 19:1\u201322","journal-title":"Mol Cancer"},{"key":"1526_CR202","first-page":"1","volume":"20","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li Y (2020) Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p\/RAB11A\/WNT\/\u03b2-catenin pathway. Cancer Cell Int 20:1\u201314","journal-title":"Cancer Cell Int"},{"key":"1526_CR201","doi-asserted-by":"crossref","first-page":"pkz034","DOI":"10.1093\/jncics\/pkz034","volume":"3","author":"FF Zhang","year":"2019","unstructured":"Zhang FF, Cudhea F, Shan Z, Michaud DS, Imamura F, Eom H, Ruan M, Rehm CD, Liu J, Du M (2019) Preventable cancer burden associated with poor diet in the United States. JNCI Cancer Spectr 3:pkz034","journal-title":"JNCI Cancer Spectr"},{"key":"1526_CR200","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/s41419-021-04144-2","volume":"12","author":"B Zhang","year":"2021","unstructured":"Zhang B, Zhang M, Shen C, Liu G, Zhang F, Hou J, Yao W (2021) LncRNA PCBP1-AS1-mediated AR\/AR-V7 deubiquitination enhances prostate cancer enzalutamide resistance. Cell Death Dis 12:856","journal-title":"Cell Death Dis"},{"key":"1526_CR203","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3233\/CBM-170683","volume":"21","author":"B Zhao","year":"2018","unstructured":"Zhao B, Lu Y-L, Yang Y, Hu L-B, Bai Y, Li R-Q, Zhang G-Y, Li J, Bi C-W, Yang L-B (2018) Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a\/TGF-\u03b21\/Smad signaling pathway. Cancer Biomarkers 21:613\u2013620","journal-title":"Cancer Biomarkers"},{"key":"1526_CR204","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3892\/or.2015.4055","volume":"34","author":"L Zheng","year":"2015","unstructured":"Zheng L, Chen J, Ma Z, Liu W, Yang F, Yang Z, Wang K, Wang X, He D, Li L (2015) Capsaicin causes inactivation and degradation of the androgen receptor by inducing the restoration of miR-449a in prostate cancer. Oncol Rep 34:1027\u20131034","journal-title":"Oncol Rep"},{"key":"1526_CR205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2022.02.078","volume":"601","author":"J Zhou","year":"2022","unstructured":"Zhou J, Li J, Qian C, Qiu F, Shen Q, Tong R, Yang Q, Xu J, Zheng B, Lv J (2022) LINC00624\/TEX10\/NF-\u03baB axis promotes proliferation and migration of human prostate cancer cells. Biochem Biophys Res Commun 601:1\u20138","journal-title":"Biochem Biophys Res Commun"},{"key":"1526_CR206","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.3390\/cancers16142594","volume":"16","author":"T Zhou","year":"2024","unstructured":"Zhou T, Nguyen S, Wu J, He B, Feng Q (2024) LncRNA LOC730101 promotes Darolutamide Resistance in prostate Cancer by suppressing miR-1-3p. Cancers 16:2594","journal-title":"Cancers"},{"key":"1526_CR208","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1111\/febs.12902","volume":"281","author":"M Zhu","year":"2014","unstructured":"Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng R, Wang Y, Huang J, Xu M, Yan J (2014) Lnc RNA H19\/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. FEBS J 281:3766\u20133775","journal-title":"FEBS J"},{"key":"1526_CR209","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/ptr.6563","volume":"34","author":"M Zhu","year":"2020","unstructured":"Zhu M, Yu X, Zheng Z, Huang J, Yang X, Shi H (2020) Capsaicin suppressed activity of prostate cancer stem cells by inhibition of Wnt\/\u03b2-catenin pathway. Phytother Res 34:817\u2013824","journal-title":"Phytother Res"},{"key":"1526_CR210","doi-asserted-by":"crossref","first-page":"661184","DOI":"10.3389\/fonc.2021.661184","volume":"11","author":"X Zhu","year":"2021","unstructured":"Zhu X, Li R, Wang C, Zhou S, Fan Y, Ma S, Gao D, Gai N, Yang J (2021) Pinocembrin inhibits the proliferation and metastasis of breast cancer via suppression of the PI3K\/AKT signaling pathway. Front Oncol 11:661184","journal-title":"Front Oncol"},{"key":"1526_CR207","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41420-022-01174-3","volume":"8","author":"C Zhu","year":"2022","unstructured":"Zhu C, Wang X, Wang Y, Wang K (2022) Functions and underlying mechanisms of lncRNA HOTAIR in cancer chemotherapy resistance. Cell Death Discovery 8:383","journal-title":"Cell Death Discovery"},{"key":"1526_CR211","doi-asserted-by":"crossref","unstructured":"Zhu Y, Wang Z, Li H, Ren Z, Zi T, Qin X, Sun W, Chen X, Wu G (2024) LncRNA HCG18 promotes prostate Cancer progression by regulating miR-512-3p\/HK-2 axis. Asian Journal of Urology","DOI":"10.1016\/j.ajur.2024.01.007"}],"container-title":["Functional &amp; Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-025-01526-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01526-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:10:46Z","timestamp":1769155846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-025-01526-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":211,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1526"],"URL":"https:\/\/doi.org\/10.1007\/s10142-025-01526-z","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal ethics"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}